FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...